Rituximab Recruiting Phase 2 Trials for Malignancies, Hematologic / Haplo-Cord Transplantation Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01810588Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation